SCOPUS 정보 검색 플랫폼

Melanoma Research

Volumn 11, Issue 6, 2001, Pages 611-618

Saturable dose - Response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat

(5) Roberts, M S a Wu, Z Y a Siebert, G A a Thompson, J F b,c Smithers, B M a

a UNIVERSITY OF QUEENSLAND (Australia)

b UNIVERSITY OF SYDNEY (Australia)

c ROYAL PRINCE ALFRED HOSPITAL (Australia)

Author keywords

Dose response; Isolated limb infusion; Melanoma; Melphalan; Nude rat

Indexed keywords

CYTOTOXIC AGENT; MELPHALAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; HINDLIMB; HUMAN; HUMAN CELL; ISOLATED ORGAN; MELANOMA; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; HUMANS; MELANOMA; MELPHALAN; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; RATS, NUDE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0035215923 PISSN: 09608931 EISSN: None Source Type: Journal
DOI: 10.1097/00008390-200112000-00007 Document Type: Article

Times cited : (24)

References (31)

1
- 0032951169
- High dose chemotherapy with haematopoietic rescue in breast cancer
- (1999) Hematol Cell Ther , vol.41 , pp. 58-65
- Bezwoda, W.R.¹

2
- 0033968988
- Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - Effect of sequence
- (2000) Cancer Chemother Pharmacol , vol.45 , pp. 239-246
- Frei III, E.¹ Ara, G.² Teicher, B.³ Bunnell, C.⁴ Richardson, P.⁵ Wheeler, C.⁶ Tew, K.⁷ Elias, A.⁸

3
- 0018931869
- Dose: A critical factor in cancer chemotherapy
- (1980) Am J Med , vol.69 , pp. 585-594
- Frei, E.¹ Canellos, G.P.²

4
- 9244238682
- High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: A phase I trial
- (1996) J Clin Oncol , vol.14 , pp. 1463-1472
- Stemmer, S.M.¹ Cagnoni, P.J.² Shpall, E.J.³ Bearman, S.I.⁴ Matthes, S.⁵ Dufton, C.⁶ Day, T.⁷ Taffs, S.⁸ Hami, L.⁹ Martinez, C.¹⁰ Purdy, M.H.¹¹ Arron, J.¹² Jones, R.B.¹³

5
- 0024265247
- A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer
- (1988) J Clin Oncol , vol.6 , pp. 1377-1387
- Tannock, I.F.¹ Boyd, N.F.² DeBoer, G.³ Erlichman, C.⁴ Fine, S.⁵ Larocque, G.⁶ Mayers, C.⁷ Perrault, D.⁸ Sutherland, H.⁹

6
- 0030789085
- Chemotherapy: The more the better? Overview
- (1997) Cancer Chemother Pharmacol , vol.40
- Saijo, N.¹

7
- 0030795702
- Chemotherapy for small-cell lung cancer: More is not better
- (1997) Cancer Chemother Pharmacol , vol.40
- Saka, H.¹ Shimokata, K.²

8
- 0029966673
- Dose-response relationship of epirubicin in the treatment of post-menopausal patients with metastatic breast cancer: A randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group
- (1996) J Clin Oncol , vol.14 , pp. 1146-1155
- Bastholt, L.¹ Dalmark, M.² Gjedde, S.B.³ Pfeiffer, P.⁴ Pedersen, D.⁵ Sandberg, E.⁶ Kjaer, M.⁷ Mouridsen, H.T.⁸ Rose, C.⁹ Nielsen, O.S.¹⁰ Jakobsen, P.¹¹ Bentzen, S.M.¹²

9
- 0029144112
- VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha
- (1995) J Pathol , vol.176 , pp. 279-287
- Renard, N.¹ Nooijen, P.T.² Schalkwijk, L.³ De Waal, R.M.⁴ Eggermont, A.M.⁵ Lienard, D.⁶ Kroon, B.B.⁷ Lejeune, F.J.⁸ Ruiter, D.J.⁹

10
- 0021846834
- Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities
- (1985) Cancer Res , vol.45 , pp. 1885-1889
- Briele, H.A.¹ Djuric, M.² Jung, D.T.³ Mortell, T.⁴ Patel, M.K.⁵ Das Gupta, T.K.⁶

11
- 0028551932
- Isolated limb infusion with melphalan for recurrent limb melanoma: A simple alternative to isolated limb perfusion
- (1994) Reg Cancer Treat , vol.7 , pp. 188-192
- Thompson, J.F.¹ Waugh, R.C.² Saw, R.P.M.³ Kam, P.C.A.⁴

12
- 0031893171
- Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion
- (1998) Semin Surg Oncol , vol.14 , pp. 238-247
- Thompson, J.F.¹ Kam, P.C.² Waugh, R.C.³ Harman, C.R.⁴

13
- 0031047084
- Isolated limb perfusion with melphalan for human melanoma xenograffs in the hindlimb of nude rats: A surviving animal model
- (1997) Melanoma Res , vol.7 , pp. 19-26
- Wu, Z.¹ Roberts, M.S.² Parsons, P.G.³ Smithers, B.M.⁴

14
- 0027730268
- Physiological pharmacokinetics of solutes in the isolated perfused rat hindlimb: Characterization of the physiology with changing perfusate flow, protein content, and temperature using statistical moment analysis
- (1993) J Pharmacokinet Biopharm , vol.21 , pp. 653-688
- Wu, Z.Y.¹ Rivory, L.P.² Roberts, M.S.³

15
- 0019505057
- Mechanism of melphalan resistance developed in vitro in human melanoma cells
- (1981) Cancer Res , vol.41 , pp. 1525-1534
- Parsons, P.G.¹ Carter, F.B.² Morrison, L.³ Regius, M.S.⁴

16
- 0027940288
- Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma
- (1994) Melanoma Res , vol.4 , pp. 365-370
- Clark, J.¹ Grabs, A.J.² Parsons, P.G.³ Smithers, B.M.⁴ Addison, R.S.⁵ Roberts, M.S.⁶

17
- 0032897078
- Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
- (1999) Br J Cancer , vol.80 , pp. 161-166
- De Wilt, J.H.¹ Manusama, E.R.² Van Tiel, S.T.³ Van Ijken, M.G.⁴ Ten Hagen, T.L.⁵ Eggermont, A.M.⁶

18
- 0022360120
- Implications of kinetic heterogeneity in clinical oncology
- (1985) Semin Oncol , vol.12 , pp. 231-249
- Norton, L.¹

19
- 0028357529
- Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb
- (1994) Br J Cancer , vol.70 , pp. 151-153
- Klaase, J.M.¹ Kroon, B.B.² Beijnen, J.H.³ Van Slooten, G.W.⁴ Van Dongen, J.A.⁵

20
- 0034331035
- Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis
- (2000) Cytometry , vol.41 , pp. 172-177
- Konemann, S.¹ Schuck, A.² Malath, J.³ Rupek, T.⁴ Horn, K.⁵ Baumann, M.⁶ Vormoor, J.⁷ Rube, C.⁸ Willich, N.⁹

21
- 0026676862
- Isomers of a marine diterpene distinguish sublines of human melanoma cells on the basis of apoptosis, cell cycle arrest and differentiation markers
- (1992) Melanoma Res , vol.1 , pp. 359-366
- Takahashi, H.¹ Schumann, R.² Quinn, R.³ Briscoe, T.A.⁴ Parsons, P.G.⁵

22
- 0029561548
- Will increases in dose intensity improve outcome?
- (1995) Am J Med , vol.99
- Souhami, R.L.¹

23
- 0032906163
- Dose-intensive therapy for limited-stage small-cell lung cancer: Long-term outcome
- (1999) J Clin Oncol , vol.17 , pp. 1175
- Elias, A.¹ Ibrahim, J.² Skarin, A.T.³ Wheeler, C.⁴ McCauley, M.⁵ Ayash, L.⁶ Richardson, P.⁷ Schnipper, L.⁸ Antman, K.H.⁹ Frei III, E.¹⁰

24
- 0030740650
- Pharmacological considerations in high-dose chemotherapy
- (1997) Cancer Chemother Pharmacol , vol.40
- Sasaki, Y.¹

25
- 0029340538
- Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience
- (1995) Bull Cancer , vol.82 , pp. 561-567
- Lejeune, F.¹ Lienard, D.² Eggermont, A.³ Schraffordt Koops, H.⁴ Rosenkaimer, E.⁵ Gerain, J.⁶ Klaase, J.⁷ Kroon, B.⁸ Schmitz, P.⁹

26
- 0033952276
- TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects
- (2000) Br J Cancer , vol.82 , pp. 973-980
- Van der Veen, A.H.¹ De Wilt, J.H.² Eggermont, A.M.³ Van Tiel, S.T.⁴ Seynhaeve, A.L.⁵ Ten Hagen, T.L.⁶

27
- 0032695429
- Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ for the treatment of in-transit melanoma metastases: A multicentre randomized phase II study
- (1999) Melanoma Res , vol.9 , pp. 491-502
- Lienard, D.¹ Eggermont, A.M.² Koops, H.S.³ Kroon, B.⁴ Towse, G.⁵ Hiemstra, S.⁶ Schmitz, P.⁷ Clarke, J.⁸ Steinmann, G.⁹ Rosenkaimer, F.¹⁰ Lejeune, F.J.¹¹

28
- 0033567420
- Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells
- (1999) Biochem Pharmacol , vol.58 , pp. 655-664
- Vahrmeijer, A.L.¹ Van Dierendonck, J.H.² Schutrups, J.³ Van de Velde, C.J.⁴ Mulder, G.J.⁵

29
- 0029985727
- Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat
- (1996) Br J Surg , vol.83 , pp. 551-555
- Manusama, E.R.¹ Nooijen, P.T.² Stavast, J.³ Durante, N.M.⁴ Marquet, R.L.⁵ Eggermont, A.M.⁶

30
- 0029963270
- Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: A new anti-tumour approach
- (1996) Eur J Surg Oncol , vol.22 , pp. 152-157
- Manusama, E.R.¹ Stavast, J.² Durante, N.M.³ Marquet, R.L.⁴ Eggermont, A.M.⁵

31
- 0030728227
- Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system
- (1997) Melanoma Res , vol.7 , Issue.SUPPL. 2
- Furrer, M.¹ Altermatt, H.J.² Ris, H.B.³ Althaus, U.⁴ Ruegg, C.⁵ Lienard, D.⁶ Lejeune, F.J.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.